Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.7500
-0.0500 (-6.25%)
At close: Oct 15, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $1.36 million as of October 16, 2026. It is the 48,870th most valuable company in the world and the 6,626th biggest in the United States. Its market cap has decreased by 76.60% in one year.
Market Cap
1.36M
Enterprise Value
791.67K
Revenue
n/a
Global Rank
Country Rank
#6,626 United States
PE Ratio
0.25
ChartMarket Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 1.36M, a decrease of -85.92%. That is a compound annual growth rate of -75.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.36M | -46.02% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abpro Holdings | 2.17M |
| BioAtla | 2.13M |
| CASI Pharmaceuticals | 2.06M |
| International Stem Cell | 2.03M |
| NKGen Biotech | 1.45M |
| Avenue Therapeutics | 1.38M |
| Halberd | 1.35M |
| inTerra Resources | 1.30M |